Invention Grant
- Patent Title: Anti-viral compounds
- Patent Title (中): 抗病毒化合物
-
Application No.: US14558318Application Date: 2014-12-02
-
Publication No.: US09586978B2Publication Date: 2017-03-07
- Inventor: Mary E. Bellizzi , David A. Betebenner , Jean C. Califano , William A. Carroll , Daniel D. Caspi , David A. DeGoey , Pamela L. Donner , Charles A. Flentge , Yi Gao , Charles W. Hutchins , Douglas K. Hutchinson , Tammie K. Jinkerson , Warren M. Kati , Ryan G. Keddy , Allan C. Krueger , Wenke Li , Dachun Liu , Clarence J. Maring , Mark A. Matulenko , Christopher E. Motter , Lissa T. Nelson , Sachin V. Patel , John K. Pratt , John T. Randolph , Todd W. Rockway , Kathy Sarris , Michael D. Tufano , Seble H. Wagaw , Rolf Wagner , Kevin R. Woller
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Xu Zhang
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K16/00 ; C07F7/02 ; C07D401/14 ; C07D403/14 ; C07D405/14 ; C07D413/14 ; C07D417/14 ; C07D453/00 ; C07D491/113
Abstract:
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Public/Granted literature
- US20150087618A1 Anti-Viral Compounds Public/Granted day:2015-03-26
Information query
IPC分类:
